Concepedia

Sai Kiran S. S. Pindiprolu

SK

Statistics

Publications

20

Citations

646

H-Index

17

Active since

2016

Affiliations

JSS Academy of Higher Education and Research(Current)

Aditya Birla (India)

Jawaharlal Nehru Technological University, Kakinada

Andhra University

National Institute of Pharmaceutical Education and Research

Sai Kiran S. S. Pindiprolu is an author at JSS Academy of Higher Education and Research specializing in pharmacology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2024

20

Publications

20

Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles

Shashank Tummala, M. N. Satish Kumar, Sai Kiran S. S. Pindiprolu · Drug Delivery · 2016 · 67 citations · Full text

, , +17

Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19

Sai Kiran S. S. Pindiprolu, Sai Harshini Pindiprolu · Medical Hypotheses · 2020 · 67 citations · Full text

, , +7

RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: <i>in vitro</i> studies

Venkata Talluri Siddhartha, Sai Kiran S. S. Pindiprolu, Pavan Kumar Chintamaneni et al. · Artificial Cells Nanomedicine and Biotechnology · 2017 · 60 citations · Full text

, , +15

Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells

Sai Kiran S. S. Pindiprolu, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy et al. · Drug Development and Industrial Pharmacy · 2018 · 52 citations

, , +20

Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles

Siddhartha Venkata Talluri, Gowthamarajan Kuppusamy, Veera Venkata Satyanarayana Reddy Karri et al. · Artificial Cells Nanomedicine and Biotechnology · 2016 · 41 citations · Full text

, , +15

1–5 of 20